NEW PRODUCTS
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 20646 | TNG908 | 2760481-53-4 | ≧98.0% |  |
| TNG908 is a clinical stage MTA-cooperative PRMT5 inhibitor that is selectively active | ||||
| 20645 | CP-506 ( Synonyms: SN-36506 ) | 2227304-19-8 | 98% Min. | _2227304-19-8.png) |
| CP-506 (SN-36506) is an hypoxia-activated prodrug of a DNA-alkylating nitrogen mustar | ||||
| 20524 | Zidesamtinib ( NVL-520 ) | 2739829-00-4 | ≧98.0% |  |
| Zidesamtinib ( NVL-520 ) is a novel brain-penetrant ROS1-selective tyrosine kinase in | ||||
| 20610 | Zavondemstat | 1851412-93-5 | ≧98.0% |  |
| Zavondemstat is a KDM4 inhibitor with potential as an antineoplastic agent. | ||||
| 236271 | TP1287 | 2044686-42-0 | ≧97.0% |  |
| Alvocidib Prodrug TP-1287 is an orally bioavailable, highly soluble phosphate prodrug | ||||
| 16122736 | Lirametostat ( CPI-1205 ) | 1621862-70-1 | ≧98.0% | _1621862-70-1.png) |
| Lirametostat ( CPI-1205 ) is a potent, selective, and cofactor-competitive inhibitor | ||||
| 230402 | BI 1015550 ( Nerandomilast ) | 1423719-30-5 | ≧98.0% |  |
| BI 1015550 ( Nerandomilast )is an oral, preferential inhibitor of phosphodiesterase 4 | ||||
| 20455 | Camlipixant ( BLU-5937 ) | 1621164-74-6 | ≧98.0% | _1621164-74-6.png) |
| Camlipixant is an investigational, twice-daily oral P2X3 receptor antagonist for the | ||||
| 192142 | Upacicalcet | 1333218-50-0 | ≧98.0% |  |
| Upacicalcet (formerly SK-1403/AJT240) is a novel non-peptide calcimimetic agent that | ||||
| 20553 | Tinengotinib ( TT-00420) | 2230490-29-4 | ≧98.0% |  |
| Tinengotinib ( TT-00420) is a novel multiple kinase inhibitor that strongly inhibited | ||||
| 20548 | Pimicotinib ( ABSK02 ) | 2253123-16-7 | ≧98.0% | _2253123-16-7.png) |
| Pimicotinib is a novel small molecule inhibitor of CSF-1R, which is orally available, | ||||
| 20656 | IK-930 | 2563892-44-2 | ≧98.0% |  |
| IK-930 is a novel, selective, small molecule inhibitor of TEAD that prevents palmitat | ||||